Cancer Research UK logo.
SearchDonate
  • Search

A trial of adding pembrolizumab to chemotherapy before surgery for non small cell lung cancer (KEYNOTE-671)

Overview

Cancer types:

Lung cancer, Non small cell lung cancer (NSCLC)

Status:

Closed

Phase:

Phase 3

Details

This trial is for people whose lung cancer can be completely removed with an operation.

Recruitment start: 8 March 2018

Recruitment end: 12 November 2021

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Samreen Ahmed

Supported by

Merck Sharp & Dohme Ltd

Last reviewed: 16 Dec 2021

CRUK internal database number: 16683

Help and support